Indoco Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
May 16, 2024 at 05:08 am
Share
Indoco Remedies Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 4,390.8 million compared to INR 4,287.5 million a year ago. Revenue was INR 4,523 million compared to INR 4,286.6 million a year ago. Net income was INR 227 million compared to INR 258.1 million a year ago. Basic earnings per share from continuing operations was INR 2.39 compared to INR 2.8 a year ago. Diluted earnings per share from continuing operations was INR 2.39 compared to INR 2.8 a year ago.
For the full year, sales was INR 17,882.2 million compared to INR 16,400.5 million a year ago. Revenue was INR 18,271.4 million compared to INR 16,709.5 million a year ago. Net income was INR 984.7 million compared to INR 1,422.5 million a year ago. Basic earnings per share from continuing operations was INR 10.53 compared to INR 15.44 a year ago. Diluted earnings per share from continuing operations was INR 10.51 compared to INR 15.42 a year ago.
Indoco Remedies Limited is an India-based manufacturer of pharmaceutical products. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company offers medicines in multiple therapeutic categories, such as diabetology, respiratory, stomatology, women's health, nutritional products, gastroenterology, cardiology, metabolic disorders and primary care medicine. Its products/brands include Cyclopam, Sensodent-K, Karvol Plus, Sensoform, Cital UTI, Kidodent, Rexidin M, Lignox A, Dentogel, Aloja, Homide, Renolen, Noxa, Dexoren - S, Aloja M, ATM, Febrex Plus, Sensodent-KF, SM Fibro, MCBM 69, Cal Aid, Snowdent, Dropizin, Zincoren, Coloferrin, Bfloren, RR Sensoform Dental, Mofloren-D, and Tuspel among others. The Company caters to both domestic and international markets. Its subsidiaries include Xtend Industrial Designers and Engineers Pvt Ltd, Indoco Remedies Czech sro, and Indoco Remedies UK Limited.